Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports
Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of price negotiations, Bloomberg News reported on Tuesday citing a company executive.
President Joe Biden and Vice President Kamala Harris have repeatedly touted on the campaign trail their efforts to lower drug ...
As September approaches, Medicare beneficiaries should be on high alert for their Annual Notice of Change (ANOC). This year, ...
A House committee on Wednesday advanced legislation that would extend Medicare telehealth flexibilities and a home hospital ...
Technology alone isn't the answer. Computers can’t lay hands on a patient. We need a nuanced approach that combines advanced ...
Get ahead with us - it's free. A key overseas figure in a widespread fraud that bilked the Medicare system out of $1.2 ...
Cigna is joining the chorus of health insurance companies detailing where they will scale back Medicare Advantage offerings ...
Argus Leader on MSN11h
Denied and delayed care: Why Avera is dropping Humana Medicare AdvantageAvera Health announced Thursday via press release that the healthcare organization will end its participation as an ...
Medicare offers four ways to pay your premium online, but first you’ll need to create an account at Medicare.gov.
Wondering why you need Medicare if you have lifetime health insurance coverage under the Federal Employees Health Benefits ...
Original Medicare does not cover routine dental treatments such as root canals. However, some Medicare Advantage plans ...
It is no surprise that Medicare patients often wait weeks to months for an appointment with a new provider.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback